Remixpoint, Inc. (TYO:3825)
Japan
· Delayed Price · Currency is JPY 322.00
-14.00 (-4.17%)
Sep 26, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Energy | 20.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Energy Growth | 9.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Resilience | 1.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Resilience Growth | 12.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical | 1.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Growth | 311.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Financial Investment | -2.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Automotive | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Automotive Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finance-related | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finance-related Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Infectious Disease Counter Measure | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Japan | 21.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 3.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|